Goodfire raised $150 million in Series B funding, reaching a valuation of $1.25 billion, to enhance its AI technologies and partnerships in life sciences.

Target Company Overview

Goodfire has successfully completed a $150 million Series B funding round, following previous investments during its Seed and Series A stages, which took place last year. This latest funding elevates the company's valuation to $1.25 billion. The funding round was spearheaded by B Capital, with contributions from existing investors and new partners, including DFJ Growth, Salesforce Ventures, and notable individual investors such as Eric Schmidt.

This funding will be instrumental in advancing frontier research, enhancing the core product, and fostering partnerships within the realms of artificial intelligence and life sciences.

Industry Overview in the United States

The artificial intelligence industry in the United States is rapidly evolving, significantly impacting various sectors, including healthcare, finance, and tech

View Source

Similar Deals

Oak HC/FT, General Catalyst Chai Discovery

2025

Series B Biotechnology & Medical Research (NEC) United States of America
Oak HC/FT Chai Discovery

2025

Series B Biotechnology & Medical Research (NEC) United States of America
Redpoint Ventures Function Health

2025

Series B Medical & Diagnostic Laboratories United States of America
Five Elms Capital Ritten

2025

Series B Healthcare Facilities & Services (NEC) United States of America
Reach Capital Manifold

2025

Series B Biotechnology & Medical Research (NEC) United States of America
ARCH Venture Partners, GV (Google Ventures) Pelage Pharmaceuticals

2025

Series B Proprietary & Advanced Pharmaceuticals United States of America

B Capital

invested in

Goodfire

in 2023

in a Series B deal

Disclosed details

Transaction Size: $150M

Enterprise Value: $1,250M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert